Documents | Infliximab for the treatment of adults with psoriasis | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

Psoriasis - infliximab: Final appraisal determination and comments on ACD

Psoriasis - infliximab: Final appraisal determination and comments on ACD information
Psoriasis - infliximab: Final appraisal determination ^{PDF 86.5 KB} 30 November 2007
Response to consultee, commentator and public comments on the ACD and comments from website consultation ^{PDF 137.09 KB} 30 November 2007
Consultee and commentator comments on the ACD
Commentators
Wyeth Pharmaceuticals ^{PDF 60.08 KB} 30 November 2007
Merck Serono ^{PDF 31.68 KB} 30 November 2007
Cochrane Skin Group ^{PDF 9.46 KB} 30 November 2007
Professional and patient groups
Royal College of Physicians ^{PDF 62.57 KB} 30 November 2007
Royal College of Paediatrics and Child Health ^{PDF 12.17 KB} 30 November 2007
The Psoriasis Association ^{PDF 25.23 KB} 30 November 2007
British Association of Dermatologists ^{PDF 16.04 KB} 30 November 2007
Schering Plough Ltd ^{PDF 423.47 KB} 30 November 2007
Expert comments on the ACD: Ms Karina Jackson, Clinical Expert nominated by the British Dermatological Nursing Group ^{PDF 40.42 KB} 30 November 2007

Psoriasis - infliximab: Appraisal Consultation Document

Psoriasis - infliximab: Appraisal Consultation Document information

Psoriasis - infliximab: Evaluation report

Psoriasis - infliximab: Evaluation report
Psoriasis - infliximab: Schering-Plough Ltd ^{PDF 1.59 MB} 03 September 2007
Psoriasis - infliximab: Evidence review group report ^{PDF 445.41 KB} 03 September 2007
Pre-meeting briefing ^{PDF 174.75 KB} 24 August 2007
Psoriasis - infliximab: Non-manufacturer submissions
The Psoriasis Association ^{PDF 53.72 KB} 24 August 2007
Psoriatic Anthropathy Alliance ^{PDF 45.02 KB} 24 August 2007
British Association of Dermatologists ^{PDF 50.72 KB} 24 August 2007
British Dermatological Nursing Group ^{PDF 42.38 KB} 24 August 2007
Royal College of General Practitioners ^{PDF 16 KB} 13 September 2007
Royal College of Physicians ^{PDF 44.31 KB} 24 August 2007
Psoriasis - infliximab: Manufacturer response to clarification letter
Manufacturer response A ^{PDF 239.39 KB} 24 August 2007
Manufacturer response B ^{PDF 735.23 KB} 24 August 2007
NICE clarification letter ^{PDF 26.65 KB} 22 August 2007
Psoriasis - infliximab: Expert written personal statements
Griffiths ^{PDF 20.42 KB} 24 August 2007
Barker ^{PDF 21.89 KB} 24 August 2007
Jackson ^{PDF 23.06 KB} 24 August 2007
Edwards ^{PDF 21.25 KB} 24 August 2007
Jobling ^{PDF 20.41 KB} 24 August 2007

Medicines concordance: Final scope

Medicines concordance: Final scope ^{PDF 39.27 KB} 14 June 2007

Medicines concordance: Final scope

Medicines concordance: Final scope ^{PDF 39.27 KB} 14 June 2007

Comments on draft scope and matrix and the Institute's response

Comments on draft scope and matrix and the Institute's response ^{PDF 51.07 KB} 09 March 2007

Psoriasis - infliximab: Final scope archive

Medicines concordance: Final scope ^{PDF 39.27 KB} 14 June 2007

Psoriasis - infliximab:Appraisal consultation document (using ACD form features)

Psoriasis - infliximab:Appraisal consultation document (using ACD form features) information